Biosimilars: what clinicians should know
The European Generics medicines Association (EGA) has made this journal article by Martina Weise et al fully available on its website. Click below to download it.
Biosimilar medicines offer physicians more choices at affordable prices thereby increasing patient access without increasing overall spending.
Bending the curve of rising healthcare costs without compromising access to quality medical care for its citizens remains one of the most daunting challenges that governments are faced with.